Drug Delivery Technology – assess products, developments, and revenue prospects What does the future hold for the drug delivery technologies market? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects.
Our 204 page report provides 113 tables, charts, and graphs covering 6 leading and distinct submarkets. Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, interviews, trends, opportunities, and revenue predictions. Increasing development and use of biological drugs (biologics) will increase worldwide sales of drug delivery technologies from 2015 to 2025, our study shows.
Forecasts from 2015-2025 and other analyses show you commercial prospects Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. You will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT), company profiles and commercial developments. Read the full transcript of 5 exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales: – Dr Igor Gonda, President and CEO & David Cipolla, Senior Director of Pharmaceutical Sciences, Aradigm – Dr Claus Michael Lehr, Head of Department, Drug Delivery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) – Dr. Bridget Martell, Chief Medical Officer and Vice President of Clinical Product Development, Juniper Pharmaceuticals – John McCarter, Director of Business Development, Soluble Therapeutics – Dr Sven Frokjaer, Dean and Professor of Pharmaceutical Sciences, University of Copenhagen, Denmark
You will find prospects for key submarkets In addition to analyses of the overall world market, you will see revenue forecasting of 6 major submarkets to 2025: • Oral Drug Delivery Market Forecast 2015-2025 • Inhalable Drug Delivery Market Forecast 2015-2025 • Injectable/Implantable Drug Delivery Market Forecast 2015-2025 • Transdermal Drug Delivery Market Forecast 2015-2025 • Ocular Drug Delivery Market Forecast 2015-2025 • Nasal/Buccal Drug Delivery Market Forecast 2015-2025
Our new study also provides qualitative analyses for each submarket identifying strengths, weaknesses, opportunities and potential threats to sales growth.
How will those drug delivery markets expand? Which applications will generate the most money? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.
What are the prospects in the leading regions and countries? In our study you will find individual revenue forecasts to 2025 for the leading regional and national markets: • US • Japan • Germany • France • UK • Spain • Italy • China • India • Brazil • Russia • South Korea • Mexico • Rest of the World
Many opportunities exist within the drug delivery technologies market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints.
Leading companies and potential for market growth Overall world revenue for the drug delivery technologies market will reach $159.3bn in 2015, our work forecasts. We predict strong revenue growth from 2015 to 2025. Our work shows you what organisations hold greatest potential. See profiles of 10 leading companies and others, including: • Alkermes • 3M • Skyepharma • BD • Antares Pharma • pSivida • Applied Pharma Research • Ethypharm • Glycologic • NanoPass Technologies
In general, a company profile gives you the following information: • Overview of the company, including its history in the drug delivery technology market • Discussion of a company’s activities and outlook including descriptions of leading products • Recent financial results • Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures
What issues will affect the drug delivery technology market? Our new report discusses issues and events affecting the drug delivery technology market. You will find discussions, including qualitative analyses: • Product life cycle extension • The strong growth of biologics • Trends toward self administration • Aging population • Rising incidence of chronic diseases such as diabetes
Technologies and applications giving improved clinical efficacy, patient convenience and treatment compliance will achieve success. In particular, greater use of injectable drugs and vaccines worldwide will stimulate demand for innovative delivery systems.
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
How the Drug Delivery Technologies Market Forecast 2015-2025: Prospects for Leading Companies report helps you In summary, our 204 page report gives you the following knowledge: • Revenue forecasts to 2025 for the overall world drug delivery technology market and 6 submarkets – discover the industry’s prospects, finding promising places for investments and revenues • Assessment of leading companies, and others, discovering activities and outlooks • Market forecasting to 2025 for the leading regional and national markets – US, Japan, Germany, France, UK, Spain, Italy, China, India, Brazil, Russia, South Korea, Mexico and RoW • View opinions from our survey, seeing interviews with authorities • Investigation of competition and opportunities influencing sales • Discussion of what stimulates and restrains the drug delivery technology market
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the drug delivery technologies market. You find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Drug Delivery Technology Market Overview 1.2 Overview of Findings 1.3 Structure of the Report 1.4 Global Drug Delivery Technology Market Segmentation 1.5 Why You Should Read This Report 1.6 How This Report Delivers 1.7 Key Questions Answered by This Analytical Report 1.8 Who is This Report For? 1.9 Methodology 1.10 Frequently Asked Questions (FAQ) 1.11 Associated Visiongain Reports 1.12 About Visiongain
2. Introduction to Drug Delivery Technology 2.1 Drug Delivery Technologies (DDT) 2.1.1 Oral Drug Delivery: Enter Through the Mouth 2.1.2 Pulmonary Delivery: Delivered by Inhalation 2.1.3 Injection as a Route of Drug Delivery 2.1.4 Transdermal Delivery: More Patient-Friendly 2.1.5 Various Transmucosal Delivery Routes for Delivery 2.1.6 Ocular Delivery: Overcoming Unique Barriers 2.2 Sustained/Controlled Release Systems 2.3 Biopharmaceuticals 2.3.1 An introduction to the Biological Drugs Market 2.3.2 Biologics: A Rising Drugs Market 2.3.3 Biotech Drugs with Associated Drug Delivery Technologies 2.3.4 Pegylated Interferons 2.3.5 Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies 2.3.6 The Main Challenges Facing Biological Drug Delivery 2.4 Market Definition
3. Drug Delivery Technology: World Market 2015-2025 3.1 The Global Drug Delivery Technology Market: Overview 3.2 The Global Drug Delivery Technologies Market in 2014 3.3 The Global Drug Delivery Technology Market Forecast 2015-2025 3.4 How Will Segmental Market Shares Change to 2025? 3.5 Biologics: A Driver for Growth in Drug Delivery Technologies 3.5.1 The Global Biological Drugs Market Forecast 3.5.2 Leading Classes of Biological Drugs 3.5.3 Monoclonal Antibodies: Largest Sector in Biologics 3.5.4 Human insulin: Leading the Therapeutic Protein Segment 3.5.5 Interferon Products for the Treatment of Hepatitis 3.6 Vaccines: Meeting the Unmet Needs 3.6.1 The Global Vaccines Market Forecast 3.7 Drug Delivery Technology: Drivers and Restraints 2015-2025
4. Drug Delivery Technologies Submarkets 2015-2025 4.1 Oral Drug Delivery Technology 4.1.1 Oral Drug Delivery Technology Market Forecast 2015-2025 4.1.2 Trends and Developments 4.1.2.1 Delivering APIs to the Colon 4.1.2.2 Google Investing on Robotic Pill 4.1.2.3 Better Tools to Model Drug Absorption 4.1.3 Oral Drug Delivery Technologies: Drivers and Restraints 2015-2025 4.2 Inhalable Drug Delivery Technology 4.2.1 Inhalable Drug Delivery Technology Market Forecast 2015-2025 4.2.2 Trends and Developments 4.2.2.1 Inhalable Liposomal Antibiotics to Penetrate Biofilms 4.2.2.2 Condensation Aerosol Generated by Heat 4.2.2.3 Inhaled Insulin: Will It Succeed This Time? 4.2.3 Inhalable Drug Delivery Technologies: Drivers and Restraints 2015-2025 4.3 Injectable/Implantable Delivery Technology 4.3.1 Injectable/Implantable Delivery Technology Market Forecast 2015-2025 4.3.2 Trends and Developments 4.3.2.1 Ultrasound Activated Targeted Drug Delivery 4.3.2.2 Intradermal Vaccine Delivery 4.3.2.3 First Flu Vaccine Jet Injector Approved in the US 4.3.3 Injectable/Implantable Delivery Technologies: Drivers and Restraints 2015-2025 4.4 Transdermal Drug Delivery Technology 4.4.1 Transdermal Drug Delivery Technology Market Forecast 2015-2025 4.4.2 Trends and Developments 4.4.2.1 Iontophoretic Transdermal Patch for Migraine Approved in the US 4.4.2.2 Microneedle Patch for Vaccine Delivery 4.4.2.3 Ultrasonic Waveforms to Enlarge Skin Pores 4.5 Ocular Drug Delivery Technology 4.5.1 Ocular Drug Delivery Technology Market Forecast 2015-2025 4.5.2 Trends and Developments 4.5.2.1 Non-Surgical Microinjection to Retina and Choroid to be used for Gene Therapy 4.6 Nasal/Buccal Drug Delivery Technology 4.6.1 Nasal/Buccal Drug Delivery Technology Market Forecast 2015-2025 4.6.2 Trends and Developments 4.6.2.1 Nasal Spray with Live Attenuated Influenza Vaccine 4.6.2.2 Mucosal Vaccine Delivered through Nose or Mouth 4.6.2.3 Buccal Insulin Spray in Clinical Trials
5. Leading National Markets 2015-2025 5.1 World Drug Delivery Technology Market: Regional Forecast 2015-2025 5.1.1 How Will Regional Market Shares Change to 2025? 5.2 US Drug Delivery Technology Market 2015-2025 5.2.1 US Drug Delivery Technology Market Forecast 2015-2025 5.2.2 FDA Guideline for Combination Products 5.2.3 Eli Lilly to Establish Drug Delivery Centre 5.3 EU5 Drug Delivery Technology Market 2015-2025 5.3.1 EU5 Drug Delivery Technology Market Forecast 2015-2025 5.3.2 How Will the European National Market Shares Change to 2025? 5.3.3 The German Drug Delivery Technology Market Forecast 2015-2025 5.3.4 The French Drug Delivery Technology Market Forecast 2015-2025 5.3.5 The UK Drug Delivery Technology Market Forecast 2015-2025 5.3.6 The Spanish Drug Delivery Technology Market Forecast 2015-2025 5.3.7 The Italian Drug Delivery Technology Market Forecast 2015-2025 5.4 Japanese Drug Delivery Technology Market 2015-2025 5.4.1 Japanese Drug Delivery Technology Market Forecast 2015-2025 5.4.2 The New Sakigake Designation System May Accelerate Innovative Drug Development 5.5 Chinese Drug Delivery Technology Market 2015-2025 5.5.1 Chinese Drug Delivery Technology Market Forecast 2015-2025 5.6 Indian Drug Delivery Technology Market 2015-2025 5.6.1 Indian Drug Delivery Technology Market Forecast 2015-2025 5.7 Brazilian Drug Delivery Technology Market 2015-2025 5.7.1 Brazilian Drug Delivery Technology Market Forecast 2015-2025 5.8 Russian Drug Delivery Technology Market 2015-2025 5.8.1 Russian Drug Delivery Technology Market Forecast 2015-2025 5.9 South Korean Drug Delivery Technology Market 2015-2025 5.9.1 South Korean Drug Delivery Technology Market Forecast 2015-2025 5.10 Mexican Drug Delivery Technology Market 2015-2025 5.10.1 Mexican Drug Delivery Technology Market Forecast 2015-2025 5.11 Rest of the World Drug Delivery Technology Market 2015-2025 5.11.1 Rest of the World Drug Delivery Technology Market Forecast 2015-2025
6. Leading Companies in the Drug Delivery Technology Market 2015 6.1 Alkermes: Focused on Extended and Controlled Release 6.1.1 Alkermes: Drug Delivery Technology Portfolio 6.1.1.1 Long-Acting Injectables 6.1.1.2 Oral Controlled Release 6.1.1.3 Nanoparticle 6.1.1.4 Other Technologies 6.1.2 Alkermes: Product Portfolio 6.1.3 Alkermes: Pipeline Products 2015 6.1.4 Alkermes: Future Outlook 6.1.5 Manufacturing Facility in Georgia Sold to Recro Pharma 6.2 3M: 50 Years of Drug Delivery Technology Development 6.2.1 3M: Drug Delivery Technology Portfolio 6.2.1.1 Oral and Topical Drug Delivery 6.2.1.2 MDI for Nasal and Inhalable Drugs 6.2.1.3 Transdermal patch Technology 6.2.1.4 Microneedle Technology 6.2.2 3M: Future Outlook 6.3 Skyepharma: Solutions for Inhalable, Oral, Topical and Injectable Drugs 6.3.1 Skyepharma: Drug Delivery Technology Portfolio 6.3.1.1 Inhalation Drug Delivery Technology 6.3.1.2 Oral Drug Delivery Technology 6.3.1.3 Injectable Drug Delivery Technology 6.3.1.4 Topical Drug Delivery Technology 6.3.2 Skyepharma: Pipeline Products 2015 6.3.3 Skyepharma: Future Outlook 6.4 BD: A History of Hypodermic Needles and Syringes 6.4.1 BD: Drug Delivery Technology Portfolio 6.4.1.1 Prefillable Syringe Systems 6.4.1.2 Self-Injection Systems 6.4.1.3 Pen Needles 6.4.1.4 Safety & Shielding Systems 6.4.2 BD: Future Outlook 6.4.3 New Infusion Set with BD FlowSmart Technology Cleared by FDA 6.4.4 BD Acquired Injection Safety Firms 6.5 Antares Pharma: Leading the Needle-Free Injector Market 6.5.1 Antares Pharma: Drug Delivery Product Portfolio 6.5.2 Antares Pharma: Future Outlook 6.5.3 Antares Pharma: Products in Development 6.6 pSivida: Targeting the Back of the Eye 6.6.1 pSivida: Drug Delivery Technology Portfolio 6.6.1.1 Durasert Technology 6.6.1.2 Tethadur Technology 6.6.2 pSivida: Pipeline Products 2015 6.6.3 psidiva: Collaborations 6.6.4 pSivida: Future Outlook 6.6.5 New Funded Technology Evaluation Agreements 6.7 Applied Pharma Research (APR) 6.7.1 APR’s Technology and Product Offerings 6.8 Ethypharm 6.8.1 Ethypharm’s Currently Marketed Products 6.9 Glycologic 6.9.1 Glycologic’s Drug Delivery Technologies 6.9.2 Glycologic’s Pipeline Developments 6.10 Nanopass Technologies 6.10.1 Nanopass Drug Delivery Products 6.10.1.1 Anti-aging Microdermabrasion 6.10.1.2 Micronjet Needle
7. Qualitative Analysis of the Drug Delivery Technology Market 2015-2025 7.1 SWOT Analysis of the Drug Delivery Technology Market 7.2 Strengths 7.2.1 Increasing Competition and Patent Expiry in the Biologics Market 7.2.2 The Rise of Biosimilars 7.2.3 Increasing Global Diabetes Population 7.3 Weaknesses 7.3.1 Risk-Conscious Regulatory Bodies Will Make Approval Difficult 7.3.2 Companies Need to Develop a More Liberal Mindset 7.4 Opportunities 7.4.1 Nanotechnology: Innovations That Will Benefit Drug Delivery 7.4.2 Possible New Delivery Methods for Insulin 7.5 Threats 7.5.1 Increasing Specificity of Drug Development Poses Challenges to Speciality Drug Delivery Companies 7.5.2 Cost effective Solutions May not be Available
8. Research Interviews 8.1 Dr Igor Gonda, President and CEO & David Cipolla, Senior Director of Pharmaceutical Sciences, Aradigm 8.1.1 Aradigm and the AERx Pulmonary Drug Delivery Platform 8.1.2 The Need for Innovative Pulmonary Delivery Technologies 8.1.3 On the Competitive Landscape for the Pulmonary Drug Delivery Technology 8.1.4 Asthma and COPD Lead, Serious Lung Infections to Catch Up 8.1.5 On Global Reach and Licensing Opportunities 8.2 Dr Claus Michael Lehr, Head of Department, Drug Delivery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) 8.2.1 The Need for Novel Delivery Mechanisms Driving Growth 8.2.2 Therapeutic Areas That Are Propelling Drug Delivery Technologies 8.2.3 Drug Delivery Barriers and the Need for Targeting 8.2.4 Advancements in Drug Delivery in the Coming Years 8.2.5 Future Challenges for Drug Delivery Technologies 8.2.6 Future Opportunities for Drug Delivery Technologies 8.3 Dr. Bridget Martell, Chief Medical Officer and Vice President of Clinical Product Development, Juniper Pharmaceuticals 8.3.1 Focused on Women’s Health and Drug Delivery 8.3.2 On Competitive Landscape for Vaginally-Administered Products 8.3.3 Unique Segmented IVR Technology 8.3.4 Therapeutic Areas of BDS and IVR Technologies 8.3.5 Pipeline Candidate Addressing Unmet Needs 8.3.6 On Trends and Developments of the Market 8.4 John McCarter, Director of Business Development, Soluble Therapeutics 8.4.1 Focused on Biologics Formulation Screening Technology 8.4.2 On Trends and Developments in the Market 8.4.3 The HSC Technology is Faster and Cheaper with Lower Protein Consumption 8.4.4 Patient Convenience is the Key 8.4.5 On Important Therapeutic Areas 8.5 Dr Sven Frokjaer, Dean and Professor of Pharmaceutical Sciences, University of Copenhagen, Denmark 8.5.1 On the Current State of Drug Delivery Technologies 8.5.2 The ‘Magic Bullet’ – A Challenge for Innovation 8.5.3 Self-Assembling Protein Systems and the Use of Nanostructures for Drug Targeting 8.5.4 Technological Developments in Drug Development – Quantum Dots, Silicon Structures, and Polymeric Materials 8.5.5 On Future Challenges and Opportunities
9. Conclusions 9.1 The World Drug Delivery Technology Market in 2014 9.1.1 Current Leading Drug Delivery Technology Segments 9.1.2 Notable Drug Delivery Technology Companies 9.1.3 Leading Regional Markets 9.2 World Drug Delivery Technology Market Forecast 2015-2025 9.3 The Future of the Drug Delivery Technology Market 9.3.1 Transdermal and Injectable Drug Delivery Technologies Set For High Growth 9.3.2 Biologics and Biosimilars to Drive Market Growth
10. Glossary
List of Tables Table 1.1 Leading National Drug Delivery Technology Market Forecast 2015-2025 ($bn, AGR%, CAGR%) Table 2.1 Top 8 Biotech Drugs by Sales ($bn), 2014 Table 2.2 Top 8 Companies by Biologic Sales ($bn), 2014 Table 3.1 The Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 3.2 Global Biological Drugs Market: Revenues ($bn), AGR (%), CAGR (%), 2012-2023 Table 3.3 Global Vaccines Market: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.1 Oral Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.2 Inhalable Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.3 Insulin Inhalers Withdrawal from the Market or Pipeline, 2015 Table 4.4 Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.5 Transdermal Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.6 Ocular Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.7 Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.1 World Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Region, 2014-2025 Table 5.2 US Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.3 EU5 Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.4 German Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.5 French Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.6 UK Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.7 Spanish Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.8 Italian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.9 Japanese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.10 Chinese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.11 Indian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.12 Brazilian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.13 Russian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.14 South Korean Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.15 Mexican Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.16 Rest of the World Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2014-2025 Table 6.1 Leading Companies: Areas of Interest by Type of Delivery Table 6.2 Alkermes: Overview, 2015 Table 6.3 Alkermes: Drug Delivery Technology Portfolio and Pipeline 2015 Table 6.4 Products Utilising Alkermes’ Drug Delivery Technology (Indication, Partner and Territory) 2015 Table 6.5 Alkermes: Pipeline Products (Product Candidate, Target Indication, Status), 2015 Table 6.6 Alkermes: Revenue ($m), AGR (%), CAGR (%), 2010-2014 Table 6.7 Alkermes: Revenue ($m) by Business Segment, 2010-2014 Table 6.8 3M: Overview, 2015 Table 6.9 3M: Health Care Revenue ($m), AGR (%), CAGR (%), 2009-2014 Table 6.10 Skyepharma: Overview, 2015 Table 6.11 Skyepharma: Inhalation Drug Formulation Technology Portfolio 2015 Table 6.12 Products Utilising Skyepharma’s Inhalation Drug Delivery Technology (Product Name, Indication, Licensee, Description), 2015 Table 6.13 Skyepharma: Oral Drug Formulation Technology Portfolio (Technology, Description, Product name) 2015 Table 6.14 Products Utilising Skyepharma’s Oral Drug Delivery Technology (Product name, Indication, Licensee, Description), 2015 Table 6.15 Skyepharma: Pipeline Products 2015 (Product name, Formulation, Indication, Status, Partner Name) Table 6.16 Skyepharma: Revenue ($m), AGR (%), CAGR (%), 2010-2014 Table 6.17 Skyepharma: Revenue ($m) by Income Stream, 2010-2014 Table 6.18 BD: Overview, 2015 Table 6.19 BD: Drug Delivery Products by Segment, 2015 Table 6.20 BD: Revenue ($bn) by Geographic Region, 2012-2014 Table 6.21 BD Medical: Revenue ($m), AGR (%), CAGR (%), 2009-2014 Table 6.22 Antares Pharma: Overview, 2015 Table 6.23 Antares Pharma: Product Portfolio 2015 (Product, Drug, Partner, Indication, Territory) Table 6.24 Antares’ Revenue ($m) from Major Customers, 2010-2014 Table 6.25 Antares Pharma: Revenue ($m), AGR (%), CAGR (%), 2010-2014 Table 6.26 Antares Pharma: Products in Development 2015 (Product Name, Drug, Partner, Indication, Territory, Status) Table 6.27 pSivida: Overview, 2015 Table 6.28 Products Utilising Durasert Technology 2015 (Product, Indication, Status, Partner) Table 6.29 pSivida: Revenue ($m) by Income Stream, 2011-2014 Table 6.30 Selected Ethypharm’s Pain Relieving Products, 2015 Table 7.1 SWOT Analysis of the Drug Delivery Technology Market, 2015-2025
List of Figures Figure 1.1 South Korea Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 1.2 Global Drug Delivery Technology Market Segmentation Overview 2015 Figure 3.1 The Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025 Figure 3.2 Market Shares (%) of Leading Drug Delivery Market Segments, 2014 Figure 3.3 Market Shares (%) of Leading Drug Delivery Market Segments, 2019 Figure 3.4 Market Shares (%) of Leading Drug Delivery Market Segments, 2025 Figure 3.5 Global Biological Drugs Market: Revenues ($bn), AGR (%), 2012-2023 Figure 3.6 Global Vaccines Market: Revenues ($bn), AGR (%), 2014-2025 Figure 3.7 Drug Delivery Technologies: Market Drivers and Restraints 2015-2025 Figure 4.1 Oral Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.2 Oral Drug Delivery Technologies: Drivers and Restraints 2015-2025 Figure 4.3 Inhalable Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.4 Inhalable Drug Delivery Technologies: Drivers and Restraints 2015-2025 Figure 4.5 Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.6 Injectable/Implantable Drug Delivery Technologies: Drivers and Restraints 2015-2025 Figure 4.7 Transdermal Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.8 Ocular Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.9 Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn), AGR (%), 2014-2025 Figure 5.1 World Drug Delivery Technology Market: Revenues ($bn) by Region, 2014 Figure 5.2 World Drug Delivery Technology Market: Revenues ($bn) by Region, 2014-2025 Figure 5.3 World Drug Delivery Technology Market: Market Shares (%) by Regional Market, 2014 Figure 5.4 World Drug Delivery Technology Market: Market Shares (%) by Regional Market, 2019 Figure 5.5 World Drug Delivery Technology Market: Market Shares (%) by Regional Market, 2025 Figure 5.6 US Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.7 EU5 Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.8 EU5 Drug Delivery Technology Market: Market Shares (%) by National Market, 2014 Figure 5.9 EU5 Drug Delivery Technology Market: Market Shares (%) by National Market, 2019 Figure 5.10 EU5 Drug Delivery Technology Market: Market Shares (%) by National Market, 2025 Figure 5.11 German Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.12 French Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.13 UK Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.14 Spanish Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.15 Italian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.16 Japanese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.17 Chinese Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.18 Indian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.19 Brazilian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.20 Russian Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.21 South Korean Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.22 Mexican Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 5.23 Rest of the World Drug Delivery Technology Market Forecast: Revenues ($bn), AGR (%), 2014-2025 Figure 6.1 Alkermes: Revenue ($m), AGR (%), 2010-2014 Figure 6.2 Alkermes: Revenue ($m) by Type, 2010-2014 Figure 6.3 Alkermes: Manufacturing and royalty revenue ($m) by Product, 2010-2014 Figure 6.4 Alkermes: Revenue ($m) by Main Customers 2014 Figure 6.5 3M: Health Care Revenue ($m), AGR (%), 2009-2014 Figure 6.6 Skyepharma: Revenue ($m), AGR (%), 2010-2014 Figure 6.7 Skyepharma: Revenue ($m) by Income Stream, 2010-2014 Figure 6.8 BD: Revenue ($bn) by Geographic Region, 2012-2014 Figure 6.9 BD Medical: Revenue ($m), AGR (%), 2009-2014 Figure 6.10 Antares’ Revenue from Major Customers, 2010-2014 Figure 6.11 Antares Pharma: Revenue ($m), AGR (%), 2010-2014 Figure 6.12 pSivida: Revenue ($m) by Income Stream, 2011-2014
3M Acorda Actavis Adamis Aleza Pharmaceuticals Alkermes Almirall Alza Antares Pharma Applied Pharma Research Aradigm Astellas AstraZeneca Bayer HealthCare Pharmaceuticals BD Biogen BioGeneration Ventures Bioject Medical Technologies Boehringer Ingelheim Bristol¬Myers Squibb CareFusion Corporation Cephalon Changchun BCHT Chiesi Cilag Cima Labs Clearside Cosmo Pharmaceuticals CRISI Medical Systems CTCBIO Daiichi Elan Drug Technologies Elcam Medical Eli Lilly Ethypharm Ferring Flamel Genentech GlaxoSmithKline Glycologic Google GSK Haselmeir Horizon Pharma ImmusanT Innovent Biologics Insmed Invion iScience Interventional Corporation J&J Janssen JCR Pharmaceuticals Kyorin MannKind Meda Pharmaceuticals Medac Medimetrics MedImmune MedSciences Capital Merck Serono Mucosis Mundipharma Nanopass Technologies Nektar Therapeutics Nexvax2 NHTherapeutics Novartis Novo Nordisk NuPathe NV NOM OwenMumford Pacira Pharmaceuticals Pari Pharma Permatec Pfizer PharmaJet Presspart ProStrakan pSivida Pulmagen Ranbaxy Rani Therapeutics Recro Pharma Regeneron Pharmaceuticals Roche Sandoz Sanofi-Aventis Santen Shionogi SHL Group Shreya Life Sciences Skyepharma Smoofi Spark Therapeutics STADA Arzneimittel Takeda Teva UU Holdings Vetter Pharma West Pharmaceuticals Ypsomed
Other Organisations Mentioned in This Report Emory University School of Medicine Georgia Institute of Technology Hospital for Special Surgery University of Oxford
Download sample pages
Complete the form below to download your free sample pages for Drug Delivery Technologies Market Forecast 2015-2025
Download sample pages
Complete the form below to download your free sample pages for Drug Delivery Technologies Market Forecast 2015-2025
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.
Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031
High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.
Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031
Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
